Western Drug Companies Accused Of Medical Trials On Unsuspecting East Germans
redOrbit Staff & Wire Reports - Your Universe Online Western drug companies tested pharmaceuticals on more than 50,000 people in the former communist East Germany, several of whom died, the German weekly Der Spiegel reported this week,...
Latest pharmaceutical industry Stories
Healthcare at Home Ltd (http://www.hah.co.uk), Europe’s leading provider of home-based healthcare and patient support company has joined QED Clinical Services Ltd (http://www.qed-clinical.com), a global full service clinical research organization (CRO), as part of the strategic alliance, OrphanReach. Burton, UK (PRWEB) May 17, 2013 OrphanReach is a strategic alliance that pools the vast experience, heritage, and capabilities of both Healthcare at Home and QED Clinical Services....
- IIMD China 2013 Hot Topics Preview SHANGHAI, May 17, 2013 /PRNewswire/ -- Medical devices are any medical items that are neither a drug nor a biological product. In light of their different mechanisms, actions and regulatory requirements, medical device (MD) trail evaluations are much more complicated than drug trails due to their unique clinical practices. Currently, the EMEA only evaluates MD safety instead of evaluating both safety and efficacy (which is left to the...
Researchers at the University of Cincinnati (UC) have found that the race and sex of study personnel can influence a patient’s decision on whether or not to participate in clinical research. The study, presented today at the Society for Academic Emergency Medicine’s annual meeting in Atlanta, that there is an interaction of the race and sex of the study assistant and the race of the patient. Lead author Kimberly Hart says that her team found that black patients, both male and...
CANTON, Mass., May 17, 2013 /PRNewswire/ -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that the Company's President and CEO, Michael Heffernan, will present the Company's corporate overview on Monday, May 20, 2013 at 1:30pm EDT at the UBS Global Health Care Conference. The conference will be held at the Sheraton New York Hotel in New York City. The Company's lead development program is Oxycodone DETERx(®), an abuse-deterrent,...
PITTSBURGH, May 17, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has shipped Fenofibrate Tablets, 48 mg and 145 mg. Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is the generic version of Abbvie Inc.'s Tricor(®) Tablets. Fenofibrate Tablets are indicated as adjunctive therapy to diet to reduce...
Experienced association executive to spearhead efforts to align event development and production strategies, initiate integrated product development processes and refine marketing strategies. Tampa, FL (PRWEB) May 16, 2013 ISPE announced today that it has named Barbara A. Myers, CAE, to the newly created position of Vice President of Professional Development. In her new role, Myers will be responsible for stimulating ISPE’s revenue growth by aligning event development and production...
THOUSAND OAKS, Calif., May 16, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will participate in the UBS Global Life Sciences Conference on Tuesday, May 21, 2013, at the Sheraton New York Times Square in New York City, beginning at 10:00 a.m. Eastern Daylight Time. Joseph P. Miletich, M.D., Ph.D., senior vice president of Research and Development at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website,...
REDWOOD CITY, Calif., May 16, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that Richard King, President and CEO, will present a corporate overview at the UBS Global Healthcare Conference at the Sheraton New York Hotel in New York, NY. The presentation is scheduled for Wednesday, May 22,...
AdhereTech receives $50,000 grand prize in global diabetes innovation challenge funded by Boehringer Ingelheim NEW YORK, May 16, 2013 /PRNewswire/ -- Developers of a pill bottle that wirelessly transmits data, measures medication and sends patient reminders have emerged as grand prize winners in the Healthcare Innovation World Cup, the international diabetes innovation challenge funded by Boehringer Ingelheim and organized by HITLAB. Winning team members Josh Stein, John Langhauser...
Chinese malaria drugs giant, Guilin, launches effort in Africa to enable patients and consumers detect fake malaria drugs using mobile phone technology, goldkeys. Shanghai, China (PRWEB) May 15, 2013 Guilin Pharmaceuticals, the World’s first producer of artesunate prequalified by the World Health Organisation as meeting the global body’s stringent standards for safety, quality and efficacy, has chalked another first. The company, which manages the world’s largest vertically...
